GlassScriptPhysician profile
Kendall Bell
NPI 1770115511
$648.04
in general payments reported to CMS, 2019-2025
18 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.44 · 2022: $11.76 · 2023: $19.08 · 2024: $190 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $151.16 | 2025 | Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $77.90 | 2024-2025 | Rybelsus, Ozempic |
| Amgen INC. | $54.47 | 2024 | Krystexxa |
| Janssen Pharmaceuticals, INC | $50.03 | 2021-2025 | Spravato |
| Lundbeck LLC | $39.26 | 2025 | Rexulti |
| Abbvie INC. | $39.10 | 2024-2025 | |
| Lilly USA, LLC | $33.23 | 2024-2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $25.14 | 2025 | Rexulti |
| Indivior INC. | $21.86 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.86 | 2024 | Jardiance |
| Aimmune Therapeutics, INC. | $19.43 | 2025 | Zenpep |
| Boston Scientific Corporation | $19.08 | 2023 | Lux-Dx Insertable Cardiac Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.99 | 2025 | Xifaxan |
| Glaxosmithkline, LLC. | $18.49 | 2024 | Trelegy Ellipta |
| Exact Sciences Corporation | $16.91 | 2025 | The Cologuard Plus Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $16.67 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.70 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.